methyl 2,4-dihydroxy-3,6-dimethyl benzoate has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, L; Ahmad, A; Baniahmad, A; Bartsch, S; Berndt, A; Dittmann, J; Ehsani, M; Grimm, MO; Huettner, SS; Kotolloshi, R; Mosig, AS; Neri, F; Neubert, L; Ori, A; Pungsrinont, T; Rasa, SMM; Schindler, K | 1 |
| Ghafouri-Fard, S; Hussen, BM; Rashnoo, F; Safarzadeh, A; Taheri, M | 1 |
2 other study(ies) available for methyl 2,4-dihydroxy-3,6-dimethyl benzoate and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.
Topics: Androgen Receptor Antagonists; Androgens; Angiopoietin-2; Animals; Cell Line, Tumor; Endothelial Cells; Humans; Hydroxybenzoates; Male; Mice; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Vascular Endothelial Growth Factor A | 2022 |
In silico characterization of competing endogenous RNA network in castration-resistant prostate cancer cells in presence of the natural compound atraric acid using RNA-seq analysis.
Topics: Humans; Hydroxybenzoates; Male; Prostatic Neoplasms, Castration-Resistant; RNA, Long Noncoding; Sequence Analysis, RNA | 2022 |